Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Lawrence Hookey, Queen's University
ClinicalTrials.gov Identifier:
NCT00906217
First received: May 19, 2009
Last updated: September 14, 2011
Last verified: September 2011

May 19, 2009
September 14, 2011
January 2009
July 2010   (final data collection date for primary outcome measure)
serum electrolyte changes pre and post preparation [ Time Frame: 2 months ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00906217 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population
Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population

This study aims to further define the appropriate population for Pico-Salax, a purgative used prior to colonoscopy. Patients over the age of 70 years with normal renal function scheduled for colonoscopy will receive Pico-Salax and have pre and post preparation bloodwork and electrocardiograms (ECGs).

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

patients older than 70 scheduled for colonoscopy

Colon Cleansing
Not Provided
elderly patients
patients older than 70 years with normal renal function
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
September 2011
July 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • >70 years

Exclusion Criteria:

  • renal dysfunction
  • congestive heart failure
  • ileus
Both
70 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00906217
Hookey Picosalax Elderly Trial
No
Lawrence Hookey, Queen's University
Queen's University
Not Provided
Principal Investigator: Lawrence Hookey, MD Queen's University
Queen's University
September 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP